Clopidogrel gene and stent thrombosis
Links shared publicly online about this topic.
- 2,262total visits
Clopidogrel gene and stent thrombosis
View full resource at theheart.org
Tags: Heart, Genes, Anti-Clotting Medication, Plavix, Iscover
Most Recently Shared on February 12, 2009 at 11:36 pm By:
Clopidogrel gene mutation linked to higher rate of stent thrombosis http://tinyurl.com/cxm6jp
MedWire News - Thrombosis - Early stent thrombosis predictors identified
medwire-news.md — “MedWire News Variants in three genes associated with clopidogrel metabolism and platelet receptor function are independently associated with early stent thrombosis in patients undergoing percutaneous coronary intervention, study data show. MedWire News” View full resource at medwire-news.md
Most Recently Shared on October 27, 2011 at 9:25 am By:
Early stent thrombosis predictors identified http://t.co/e1Dcb2dA
Subacute Stent Thrombosis Owing to Complete Clopidogrel Resistance Successfully Managed with Prasugrel | Journal of Invasive Cardiology
invasivecardiology.com — “Subacute Stent Thrombosis Owing to Complete Clopidogrel Resistance Successfully Managed with Prasugrel | Journal of Invasive Cardiology” View full resource at invasivecardiology.com
Most Recently Shared on July 28, 2011 at 3:37 pm By:
Invasive Cardiology Medical Journal and Cardiology
Subacute Stent Thrombosis Owing to Complete Clopidogrel Resistance Successfully Managed with Prasugrel. http://t.co/4hc03eO
Internal Medicine - Cardiology Article | Myocardial infarction
mdlinx.com — “Relationship between clopidogrel-induced platelet P2Y12 inhibition and stent thrombosis or myocardial infarction after percutaneous coronary intervention-A case-control study” View full resource at mdlinx.com
Most Recently Shared on July 27, 2011 at 7:08 pm By:
Roger D. Jones, PhD PhD, Doctor, Health Executive, and Health Social Media
Internal Medicine - Cardiology Article | Myocardial infarction: http://t.co/Iw8hZ85 #Medicine
Study examines outcomes of high-dose antiplatelet drug after stent placement
physorg.com — “Modifying a patient's dosage of the antiplatelet drug clopidogrel for 6 months depending on the patient's level of platelet reactivity did not result in combined lower rates of nonfatal heart attack, stent thrombosis (clot) and cardiovascular death in patients who had a procedure such as balloon angioplasty ...” View full resource at physorg.com
Most Recently Shared on March 15, 2011 at 9:08 pm By:
PhysOrg Health News Health News
Study examines outcomes of high-dose antiplatelet drug after stent placement http://tw.physorg.com/219427381
Study Examines Outcomes of High-Dose Antiplatelet Drug After Stent Placement
newswise.com — “Modifying a patient--™s dosage of the antiplatelet drug clopidogrel for 6 months depending on the patient--™s level of platelet reactivity did not result in combined lower rates of nonfatal heart attack, stent thrombosis (clot) and cardiovascular death in patients who had a procedure such as balloon angioplasty and received a drug-releasing coronary stent, according to a study in the March 16 issue of JAMA.” View full resource at newswise.com
Most Recently Shared on March 15, 2011 at 8:23 pm By:
newswise Health Communicator and Health News
Study Examines Outcomes of High-Dose Antiplatelet Drug After Stent Placement: Modifying a patient's dosage of th... http://bit.ly/hOcHHY
Study Examines Outcomes of High-Dose Antiplatelet Drug After Stent Placement
newswise.com — “Modifying a patient--™s dosage of the antiplatelet drug clopidogrel for 6 months depending on the patient--™s level of platelet reactivity did not result in combined lower rates of nonfatal heart attack, stent thrombosis (clot) and cardiovascular death in patients who had a procedure such as balloon angioplasty and received a drug-releasing coronary stent, according to a study in the March 16 issue of JAMA.” View full resource at newswise.com
Most Recently Shared on March 15, 2011 at 8:21 pm By:
#health news: Study Examines Outcomes of High-Dose Antiplatelet Drug After Stent Placement: Modifying a patient'... http://bit.ly/hmS7Qs
Genetic variations linked with worse outcomes with use of antiplatelet drug for cardiac procedures
eurekalert.org — “An analysis of data from previously published studies indicates that use of the antiplatelet drug clopidogrel for patients who have common genetic variants of a certain gene and are undergoing a procedure such as coronary stent placement have an associated increased risk for major adverse cardiovascular events, particularly development of blood clots in stents, according to a study in the Oct. 27 issue of JAMA.” View full resource at eurekalert.org
Most Recently Shared on October 26, 2010 at 9:34 pm By:
Genetic variations linked with worse outcomes with use of antiplatelet drug for cardiac procedures: ( JAMA and Arc... http://bit.ly/94oABn
Gene Mutations May Blunt Plavix's Effectiveness, Study Finds - Drugs.com MedNews
drugs.com — “People with certain gene variants who take the blood-thinning drug Plavix (clopidogrel) may be at increased risk for serious complications after coronary stent” View full resource at drugs.com
Most Recently Shared on October 26, 2010 at 9:29 pm By:
Gene Mutations May Blunt Plavix's Effectiveness, Study Finds - http://bit.ly/cTT53h
Gene Mutations May Blunt Plavix's Effectiveness, Study Finds - Drugs.com MedNews
drugs.com — “People with certain gene variants who take the blood-thinning drug Plavix (clopidogrel) may be at increased risk for serious complications after coronary stent” View full resource at drugs.com
Most Recently Shared on October 26, 2010 at 9:13 pm By:
Drugs and Devices OW OW Health
Gene Mutations May Blunt Plavix's Effectiveness, Study Finds: TUESDAY, Oct. 26 -- People with certain gene va... http://bit.ly/bkpa2p #drug
Clopidogrel response and cardiac death | theheart.org
theheart.org — “A platelet-reactivity index of over 60% on the VASP test was associated with an increased rate of death and stent thrombosis. The deleterious impact of a low response to clopidogrel was significantly higher in patients who received a drug-eluting stent.” View full resource at theheart.org
Most Recently Shared on June 28, 2010 at 11:19 am By:
James Rudd Internist, Cardiologist, Physician, and Doctor
Higher hard event rate with clopidogrel resistance after stenting http://www.theheart.org/article/1091207.do
PPIs, clopidogrel, and stents
theheart.org — “Another retrospective analysis, this time in stented patients, shows no significant increases in risk of death, ACS, or stent thrombosis in patients taking concomitant proton-pump inhibitors, mostly pantoprazole. But one expert says no conclusions can be made until the FDA reveals the data it used to decide that a warning was warranted.” View full resource at theheart.org
Most Recently Shared on June 1, 2010 at 10:38 pm By:
PPIs, clopidogrel, and stent implantation: No risk? FDA data coming soon: Another retrospective analysis, this tim... http://bit.ly/akQLR8
Cardiology Medical News about Clopidogrel
mdlinx.com — “High Maintenance Dosage of Clopidogrel is Associated with a Reduced Risk of Stent Thrombosis in Clopidogrel-Resistant Patients” View full resource at mdlinx.com
Most Recently Shared on February 11, 2010 at 12:55 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Cardio: High Maintenance Dosage of Clopidogrel is Associated with a Reduced Risk of Stent Thrombosis in Clopidogre... http://bit.ly/bMDg0l
Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period " Eur Heart J
eurheartj.oxfordjournals.org — “Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period " Eur Heart J” View full resource at eurheartj.oxfordjournals.org
Most Recently Shared on November 25, 2009 at 10:48 am By:
European Cardiology Cardiology and Medical Society
Stent thrombosis after DES implantation: incidence, timing and relation to discontinuation of clopidogrel therapy http://tinyurl.com/ybu8c5p
Quest Diagnostics' DNA testing for gene variants help improve outcomes for stent recipients
news-medical.net — “DNA testing for gene variants that can increase the risk of major coronary events in certain patients taking the anti-clotting drug Plavix® (clopidogrel bisulfate) is now being performed by Quest Diagnostics for Scripps Health patients electing to undergo coronary stent procedures.” View full resource at news-medical.net
Most Recently Shared on October 8, 2009 at 7:07 pm By:
Genetics News: Quest Diagnostics' DNA testing for gene variants help improve outcomes for stent r.. http://chilp.it/?f88544
Quest Diagnostics Brings Genetic Testing For Plavix(R) Response To Coronary Stent Patients At Scripps Health
medicalnewstoday.com — “Dna testing for gene variants that can increase the risk of major coronary events in certain patients taking the anti-clotting drug plavix® (clopidogrel bisulfate) is now being performed by qu” View full resource at medicalnewstoday.com
Most Recently Shared on October 8, 2009 at 1:33 pm By:
MedicalNewsToday: Quest Diagnostics Brings Genetic Testing For Plavix(R) Response To Coronary http://bit.ly/iXlFE Full http://bit.ly/UBpKH
Advertisement
